NO20055316L - Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike - Google Patents

Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike

Info

Publication number: NO20055316L
Authority: NO; Norway
Prior art keywords: pharmaceutical compositions; compositions containing; heterocyclic compounds; inflammatory; processes
Prior art date: 2003-04-11

Application number

NO20055316A

Other languages

English (en)

Norwegian (no)

Other versions

NO20055316D0 (no

Inventor

Aftab Dawoodbhai Lakdawala

Balasubramanian Gopalan

Laxmikant Atmaram Gharat

Usha Karaunakaran

Original Assignee

Glenmark Pharmaceuticals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-11

Filing date

2005-11-10

Publication date

2006-01-11

2005-11-10 Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa

2005-11-10 Publication of NO20055316D0 publication Critical patent/NO20055316D0/no

2006-01-11 Publication of NO20055316L publication Critical patent/NO20055316L/no

Links

150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
230000000172 allergic effect Effects 0.000 title 1
208000010668 atopic eczema Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1
238000000034 method Methods 0.000 title 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
150000001204 N-oxides Chemical class 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20055316A 2003-04-11 2005-11-10 Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike NO20055316L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN363MU2003		2003-04-11
US51996703P	2003-11-13	2003-11-13
PCT/IB2004/000355 WO2004089940A1 (fr)	2003-04-11	2004-02-11	Nouveaux composes heterocycliques pour le traitement des affections inflammatoires et allergiques, leur procede de preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number	Publication Date
NO20055316D0 NO20055316D0 (no)	2005-11-10
NO20055316L true NO20055316L (no)	2006-01-11

Family

ID=36947516

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055316A NO20055316L (no)	2003-04-11	2005-11-10	Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike

Country Status (34)

Country	Link
US (4)	US7223789B2 (fr)
EP (1)	EP1620429B1 (fr)
JP (1)	JP2006522789A (fr)
KR (1)	KR20060017494A (fr)
CN (1)	CN1829711B (fr)
AP (1)	AP2008A (fr)
AR (1)	AR043199A1 (fr)
AT (1)	ATE427308T1 (fr)
AU (1)	AU2004228453B2 (fr)
BR (1)	BRPI0409747A (fr)
CA (1)	CA2522023A1 (fr)
CL (1)	CL2004000526A1 (fr)
CO (1)	CO5700824A2 (fr)
DE (1)	DE602004020332D1 (fr)
DK (1)	DK1620429T3 (fr)
EA (1)	EA010634B1 (fr)
ES (1)	ES2320888T3 (fr)
GE (1)	GEP20084526B (fr)
HR (1)	HRP20050944A2 (fr)
IS (1)	IS8123A (fr)
MA (1)	MA27801A1 (fr)
MX (1)	MXPA05010948A (fr)
MY (1)	MY136516A (fr)
NO (1)	NO20055316L (fr)
NZ (1)	NZ542882A (fr)
OA (1)	OA13154A (fr)
PL (1)	PL378813A1 (fr)
PT (1)	PT1620429E (fr)
SI (1)	SI1620429T1 (fr)
TN (1)	TNSN05252A1 (fr)
TW (1)	TW200508212A (fr)
UA (1)	UA79558C2 (fr)
WO (1)	WO2004089940A1 (fr)
ZA (1)	ZA200508240B (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004037805A1 (fr) *	2002-10-23	2004-05-06	Glenmark Pharmaceuticals Ltd.	Nouveaux composes tricycliques utiles pour traiter les troubles inflammatoires et allergiques, procede de preparation de ces composes et compositions pharmaceutiques les contenant
WO2004089940A1 (fr) *	2003-04-11	2004-10-21	Glenmark Pharmaceuticals S.A.	Nouveaux composes heterocycliques pour le traitement des affections inflammatoires et allergiques, leur procede de preparation et compositions pharmaceutiques les contenant
WO2006040652A2 (fr) *	2004-10-13	2006-04-20	Glenmark Pharmaceuticals S.A.	Procede de preparation de n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
WO2006051390A1 (fr) *	2004-11-10	2006-05-18	Glenmark Pharmaceuticals S.A.	Composes heterocycliques utilises pour le traitement de troubles inflammatoires et allergiques, compositions pharmaceutiques contenant ces composes et procedes permettant de les preparer
DK1831227T3 (da)	2004-12-17	2013-08-19	Glenmark Pharmaceuticals Sa	Hidtil ukendte, heterocykliske forbindelser, der er anvendelige til behandling af inflammatoriske og allergiske forstyrrelser
AP2334A (en) *	2004-12-17	2011-12-06	Glenmark Pharmaceuticals Sa	Novel heterocyclic compounds useful for the treatment of inflamatory and allergic disorders.
US8119655B2 (en) *	2005-10-07	2012-02-21	Takeda Pharmaceutical Company Limited	Kinase inhibitors
ES2378281T3 (es) *	2006-07-05	2012-04-10	Nycomed Gmbh	Combinación de atorvastatina con un inhibidor de fosfodiesterasa 4 para el tratamiento de neumopatías inflamatorias
WO2008005955A2 (fr)	2006-07-06	2008-01-10	Forest Laboratories Holdings Limited	Synthèse de composés hétérocycliques
US20100056791A1 (en) *	2006-09-01	2010-03-04	Yasushi Kohno	Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same
US20090318385A1 (en) *	2006-09-06	2009-12-24	Yasushi Kohno	Pyrazolopyride derivative and phosphodiesterase ( pde) inhibitors containing the same as active ingredient
RU2009113585A (ru) *	2006-09-11	2010-10-20	Матрикс Лэборетериз Лтд. (In)	Производные дибензофурана в качестве ингибиторов pde-4 и pde-10
JP2010507674A (ja) *	2006-10-27	2010-03-11	ワイスエルエルシー	マトリクスメタロプロテアーゼ阻害剤としての三環式化合物
WO2008065522A2 (fr) *	2006-11-29	2008-06-05	Glenmark Pharmaceuticals S.A.	Procédé de synthèse du 4-difluorométhoxy-8-nitro-1-formyl-dibenzo[b,d]furane, un intermédiaire d'inhibiteurs de la pde4
US20100098641A1 (en) *	2006-12-13	2010-04-22	William Baker	Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction
WO2008100800A1 (fr) *	2007-02-09	2008-08-21	Forest Laboratories Holdings Limited	Formulations biodisponibles de composés hétérocycliques
US8524905B2 (en)	2007-05-22	2013-09-03	Glenmark Pharmaceuticals S.A.	Processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-c]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of PDE IV inhibitors
WO2008157205A2 (fr) *	2007-06-15	2008-12-24	Duke University	Procédés et compositions pour le traitement des infections de l'appareil urinaire en utilisant des agents qui imitent ou augmentent l'amp cyclique
EP2070913A1 (fr)	2007-12-14	2009-06-17	CHIESI FARMACEUTICI S.p.A.	Dérivés d'ester en tant qu'inhibiteurs de la phosphodiestérase
WO2009147476A1 (fr) *	2008-06-02	2009-12-10	Matrix Laboratories Ltd.	Nouveaux inhibiteurs de phosphodiestérases, compositions pharmaceutiques les contenant et leurs procédés de préparation
TWI474282B (zh) *	2008-10-03	2015-02-21	Himax Tech Ltd	深度相關的影像加強
ES2443948T3 (es)	2008-12-19	2014-02-21	Bristol-Myers Squibb Company	Compuestos de carbazol carboxamida útiles como inhibidores de quinasas
WO2011132051A2 (fr) *	2010-04-19	2011-10-27	Glenmark Pharmaceuticals S.A.	Composés tricycliques en tant qu'inhibiteurs de la phosphodiestérase-10
JP6144627B2 (ja) *	2010-12-15	2017-06-07	コントラヴィアファーマシューティカルズ、インク．	アミノ酸１および３で修飾されたシクロスポリン類似体分子
WO2014133020A1 (fr) *	2013-02-28	2014-09-04	エーザイ・アール・アンド・ディー・マネジメント株式会社	Agent permettant de prévenir et de traiter une maladie respiratoire
CN104177612A (zh) *	2013-05-28	2014-12-03	韩文毅	一种新的非线性聚合物及其制备和用途
CN104211947A (zh) *	2013-05-31	2014-12-17	韩文毅	一种非线性聚合物及其制备和用途
CN104211949A (zh) *	2013-06-04	2014-12-17	韩文毅	一种非线性聚合物及其制备与用途
CN104211950A (zh) *	2013-06-04	2014-12-17	韩文毅	一种非线性聚合物及其制备与用途
ES2928164T3 (es)	2015-10-19	2022-11-15	Incyte Corp	Compuestos heterocíclicos como inmunomoduladores
MD3377488T2 (ro)	2015-11-19	2023-02-28	Incyte Corp	Compuși heterociclici ca imunomodulatori
MA44075A (fr)	2015-12-17	2021-05-19	Incyte Corp	Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
MY199705A (en)	2015-12-22	2023-11-20	Incyte Corp	Heterocyclic compounds as immunomodulators
RU2616617C1 (ru) *	2016-04-12	2017-04-18	Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук	5-(9-этил-9Н-карбазол-3-ил)-4-[5-(9-этил-9Н-карбазол-3-ил)-тиофен-2-ил]-пиримидин
WO2017192961A1 (fr)	2016-05-06	2017-11-09	Incyte Corporation	Composés hétérocycliques utilisés comme immunomodulateurs
WO2017205464A1 (fr)	2016-05-26	2017-11-30	Incyte Corporation	Composés hétérocycliques utilisés comme immunomodulateurs
KR102685249B1 (ko)	2016-06-20	2024-07-17	인사이트 코포레이션	면역조절제로서의 복소환식 화합물
MA45669A (fr)	2016-07-14	2019-05-22	Incyte Corp	Composés hétérocycliques utilisés comme immunomodulateurs
WO2018044783A1 (fr)	2016-08-29	2018-03-08	Incyte Corporation	Composés hétérocycliques utilisés comme immunomodulateurs
EP3558989B1 (fr)	2016-12-22	2021-04-14	Incyte Corporation	Dérivés de triazolo[1,5-a]pyridine en tant qu'immunomodulateurs
CA3047991A1 (fr)	2016-12-22	2018-06-28	Incyte Corporation	Composes heteroaromatiques bicycliques utilises en tant qu'immunomodulateurs
PE20191532A1 (es)	2016-12-22	2019-10-23	Incyte Corp	Compuestos heterociclicos como inmunomoduladores
EP3558973B1 (fr)	2016-12-22	2021-09-15	Incyte Corporation	Dérivés pyridine utilisés en tant qu'immunomodulateurs
RS64055B1 (sr)	2018-03-30	2023-04-28	Incyte Corp	Heterociklična jedinjenja kao imunomodulatori
MD3790877T2 (ro)	2018-05-11	2023-08-31	Incyte Corp	Derivați de tetrahidro-imidazo[4,5-c]piridină în calitate de imunomodulatori PD-L1
CN109651232A (zh) *	2018-12-12	2019-04-19	河北华清光电材料有限公司	制备4-溴咔唑及其衍生物的方法
JP7665593B2 (ja)	2019-08-09	2025-04-21	インサイト・コーポレイション	Ｐｄ－１／ｐｄ－ｌ１阻害剤の塩
AR120109A1 (es)	2019-09-30	2022-02-02	Incyte Corp	Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores
PE20230407A1 (es)	2019-11-11	2023-03-07	Incyte Corp	Sales y formas cristalinas de un inhibidor de pd-1/pd-l1
WO2022099018A1 (fr)	2020-11-06	2022-05-12	Incyte Corporation	Procédé de préparation d'un inhibiteur de pd-1/pd-l1
TW202233616A (zh)	2020-11-06	2022-09-01	美商英塞特公司	用於製備ｐｄ－１／ｐｄ－ｌ１抑制劑以及其鹽及結晶形式之方法
WO2022099075A1 (fr)	2020-11-06	2022-05-12	Incyte Corporation	Forme cristalline d'un inhibiteur pd-1/pd-l1
CN114163417B (zh) *	2021-12-06	2023-08-04	郑州海阔光电材料有限公司	一种3-溴硫芴的合成方法
JP2024052082A (ja) *	2022-09-30	2024-04-11	静岡県	Ｐｄ－１及び／又はｐｄ－ｌ１の結合剤

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1041861A (en)	1962-03-14	1966-09-07	Organon Labor Ltd	Pyrrolidone derivatives and pharmaceutical preparations containing them
NL7008628A (fr) *	1969-06-25	1970-12-29
US3759948A (en) *	1969-06-25	1973-09-18	Merck & Co Inc	Non-steroid anti-inflammatory compounds
NL7016899A (fr)	1969-12-03	1971-06-07
US3846553A (en) *	1969-12-03	1974-11-05	Merck & Co Inc	3-substituted-2-pyridones in the treatment of pain, fever or inflammation
US4222944A (en) *	1978-07-31	1980-09-16	Hoffmann-La Roche Inc.	Halo-3-dibenzofuran alkanonitriles
JPS62158253A (ja)	1985-12-28	1987-07-14	Kirin Brewery Co Ltd	４−アミノピリジンアミド誘導体
JPH0812430B2 (ja)	1986-07-07	1996-02-07	キヤノン株式会社	電子写真感光体
US5202344A (en)	1990-12-11	1993-04-13	G. D. Searle & Co.	N-substituted lactams useful as cholecystokinin antagonists
IE71647B1 (en)	1991-01-28	1997-02-26	Rhone Poulenc Rorer Ltd	Benzamide derivatives
US5602173A (en)	1992-04-02	1997-02-11	Smithkline Beecham Corporation	Compounds useful for treating allergic and inflammatory diseases
ES2227519T3 (es)	1992-07-28	2005-04-01	Aventis Pharma Limited	Inhibidores de c-amp-fosfodiesterasa.
MX9306311A (es) *	1992-10-13	1994-04-29	Smithkline Beecham Plc	Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
US5814651A (en)	1992-12-02	1998-09-29	Pfizer Inc.	Catechol diethers as selective PDEIV inhibitors
GB9304920D0 (en)	1993-03-10	1993-04-28	Celltech Ltd	Chemical compounds
DE59410119D1 (de)	1993-07-02	2002-06-20	Byk Gulden Lomberg Chem Fab	Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
GB9315595D0 (en)	1993-07-28	1993-09-08	Res Inst Medicine Chem	New compounds
WO1995009837A1 (fr)	1993-10-01	1995-04-13	Smithkline Beecham Corporation	Composes cyano
GB9401460D0 (en)	1994-01-26	1994-03-23	Rhone Poulenc Rorer Ltd	Compositions of matter
GB9404706D0 (en)	1994-03-11	1994-04-27	Smithkline Beecham Corp	Compounds
RU2152385C1 (ru)	1994-07-27	2000-07-10	Санкио Компани Лимитед	Гетероциклические соединения, применимые в качестве аллостерических эффекторов при мускариновых рецепторах
KR20000068414A (ko) *	1996-09-04	2000-11-25	로즈 암스트롱, 크리스틴 에이. 트러트웨인	매트릭스 메탈로프로테이나제 억제제 및 그의 치료적 용도
CA2324226C (fr)	1998-03-19	2012-06-05	Vertex Pharmaceuticals Incorporated	Inhibiteurs de caspases
US6110962A (en) *	1998-05-12	2000-08-29	American Home Products Corporation	11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho[2,3-D]thiophenes useful in the treatment of insulin resistance and hyperglycemia
WO1999058521A1 (fr)	1998-05-12	1999-11-18	American Home Products Corporation	11-ARYL-BENZO[B]NAPHTO[2,3-D]FURANES ET 11-ARYL-BENZO[b]NAPHTO[2,3-d]THIOPHENES UTILES DANS LES TRAITEMENTS DE LA RESISTANCE INSULINIQUE ET DE L'HYPERGLYCEMIE
US6887870B1 (en)	1999-10-12	2005-05-03	Bristol-Myers Squibb Company	Heterocyclic sodium/proton exchange inhibitors and method
CN1481377A (zh)	2000-03-17	2004-03-10	��˹�ж�-��˹˹��ҩƷ��˾	作为基质金属蛋白酶和TNF-α的抑制剂的环β-氨基酸衍生物
DE60125026T2 (de)	2000-03-23	2007-06-28	Takeda Pharmaceutical Co. Ltd.	Fluorisochinolinderivate, verfahren zu ihrer herstellung und ihre anwendung
EP1847263A3 (fr) *	2000-12-18	2009-08-26	Institute of Medicinal Molecular Design, Inc.	Inhibiteurs de production et de libération de cytokines inflammatoires
AU2002228316A1 (en) *	2001-01-29	2002-08-12	Insight Strategy And Marketing Ltd	Carbazole derivatives and their uses as heparanase inhibitors
AU2002306687A1 (en)	2001-03-13	2002-09-24	Glenmark Pharmaceuticals Limited	Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
US7378428B2 (en) *	2002-01-31	2008-05-27	Ono Pharmaceutical Co., Ltd.	Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
AU2003253130A1 (en)	2002-08-19	2004-03-03	Glenmark Pharmaceuticals Limited	Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders
AU2003263393A1 (en)	2002-09-04	2004-03-29	Glenmark Pharmaceuticals Limited	New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
WO2004037805A1 (fr) *	2002-10-23	2004-05-06	Glenmark Pharmaceuticals Ltd.	Nouveaux composes tricycliques utiles pour traiter les troubles inflammatoires et allergiques, procede de preparation de ces composes et compositions pharmaceutiques les contenant
WO2004089940A1 (fr) *	2003-04-11	2004-10-21	Glenmark Pharmaceuticals S.A.	Nouveaux composes heterocycliques pour le traitement des affections inflammatoires et allergiques, leur procede de preparation et compositions pharmaceutiques les contenant
DK1831227T3 (da) *	2004-12-17	2013-08-19	Glenmark Pharmaceuticals Sa	Hidtil ukendte, heterocykliske forbindelser, der er anvendelige til behandling af inflammatoriske og allergiske forstyrrelser

2004
- 2004-02-11 WO PCT/IB2004/000355 patent/WO2004089940A1/fr not_active Ceased
- 2004-02-11 BR BRPI0409747-5A patent/BRPI0409747A/pt not_active IP Right Cessation
- 2004-02-11 EP EP04710093A patent/EP1620429B1/fr not_active Expired - Lifetime
- 2004-02-11 DE DE602004020332T patent/DE602004020332D1/de not_active Expired - Lifetime
- 2004-02-11 CN CN2004800160486A patent/CN1829711B/zh not_active Expired - Fee Related
- 2004-02-11 OA OA1200500280A patent/OA13154A/en unknown
- 2004-02-11 PT PT04710093T patent/PT1620429E/pt unknown
- 2004-02-11 EA EA200501617A patent/EA010634B1/ru not_active IP Right Cessation
- 2004-02-11 CA CA002522023A patent/CA2522023A1/fr not_active Abandoned
- 2004-02-11 AP AP2005003424A patent/AP2008A/xx active
- 2004-02-11 DK DK04710093T patent/DK1620429T3/da active
- 2004-02-11 AT AT04710093T patent/ATE427308T1/de not_active IP Right Cessation
- 2004-02-11 ES ES04710093T patent/ES2320888T3/es not_active Expired - Lifetime
- 2004-02-11 AU AU2004228453A patent/AU2004228453B2/en not_active Expired - Fee Related
- 2004-02-11 PL PL378813A patent/PL378813A1/pl not_active Application Discontinuation
- 2004-02-11 KR KR1020057019359A patent/KR20060017494A/ko not_active Ceased
- 2004-02-11 SI SI200431133T patent/SI1620429T1/sl unknown
- 2004-02-11 JP JP2006506259A patent/JP2006522789A/ja active Pending
- 2004-02-11 GE GEAP20049048A patent/GEP20084526B/en unknown
- 2004-02-11 HR HR20050944A patent/HRP20050944A2/xx not_active Application Discontinuation
- 2004-02-11 NZ NZ542882A patent/NZ542882A/en unknown
- 2004-02-11 MX MXPA05010948A patent/MXPA05010948A/es active IP Right Grant
- 2004-02-17 AR ARP040100483A patent/AR043199A1/es unknown
- 2004-02-24 TW TW093104603A patent/TW200508212A/zh unknown
- 2004-03-09 MY MYPI20040813A patent/MY136516A/en unknown
- 2004-03-15 CL CL200400526A patent/CL2004000526A1/es unknown
- 2004-04-09 US US10/821,642 patent/US7223789B2/en not_active Expired - Lifetime
- 2004-11-02 UA UAA200510680A patent/UA79558C2/uk unknown
2005
- 2005-10-06 TN TNP2005000252A patent/TNSN05252A1/en unknown
- 2005-10-12 ZA ZA200508240A patent/ZA200508240B/en unknown
- 2005-11-09 MA MA28593A patent/MA27801A1/fr unknown
- 2005-11-10 NO NO20055316A patent/NO20055316L/no not_active Application Discontinuation
- 2005-11-10 IS IS8123A patent/IS8123A/is unknown
- 2005-11-11 CO CO05115151A patent/CO5700824A2/es not_active Application Discontinuation
2006
- 2006-09-28 US US11/536,448 patent/US7393846B2/en not_active Expired - Fee Related
- 2006-09-28 US US11/536,434 patent/US7384962B2/en not_active Expired - Fee Related
2008
- 2008-06-02 US US12/131,286 patent/US20090182143A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TW200508212A (en)	2005-03-01
AP2005003424A0 (en)	2005-12-31
US20050027129A1 (en)	2005-02-03
BRPI0409747A (pt)	2006-05-09
US7384962B2 (en)	2008-06-10
ZA200508240B (en)	2006-05-31
SI1620429T1 (sl)	2009-08-31
AU2004228453A1 (en)	2004-10-21
DK1620429T3 (da)	2009-05-18
GEP20084526B (en)	2008-11-10
US7223789B2 (en)	2007-05-29
MY136516A (en)	2008-10-31
AR043199A1 (es)	2005-07-20
MXPA05010948A (es)	2006-05-31
EP1620429A1 (fr)	2006-02-01
DE602004020332D1 (de)	2009-05-14
US7393846B2 (en)	2008-07-01
ES2320888T3 (es)	2009-05-29
HRP20050944A2 (en)	2006-02-28
CO5700824A2 (es)	2006-11-30
NO20055316D0 (no)	2005-11-10
PT1620429E (pt)	2009-04-28
KR20060017494A (ko)	2006-02-23
US20070105855A1 (en)	2007-05-10
UA79558C2 (en)	2007-06-25
TNSN05252A1 (en)	2007-07-10
OA13154A (en)	2006-12-13
EA200501617A1 (ru)	2006-04-28
MA27801A1 (fr)	2006-03-01
CA2522023A1 (fr)	2004-10-21
CN1829711A (zh)	2006-09-06
CN1829711B (zh)	2010-06-16
CL2004000526A1 (es)	2005-03-18
US20090182143A1 (en)	2009-07-16
WO2004089940A1 (fr)	2004-10-21
JP2006522789A (ja)	2006-10-05
PL378813A1 (pl)	2006-05-29
EP1620429B1 (fr)	2009-04-01
EA010634B1 (ru)	2008-10-30
IS8123A (is)	2005-11-10
US20070105854A1 (en)	2007-05-10
ATE427308T1 (de)	2009-04-15
AP2008A (en)	2009-06-29
NZ542882A (en)	2007-10-26
AU2004228453B2 (en)	2010-08-19

Legal Events

Date	Code	Title	Description
2011-09-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
TW200508212A (en)	2005-03-01	Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
AU2022221407B2 (en)	2024-03-07	Modulators of estrogen receptor proteolysis and associated methods of use
NO20075059L (no)	2007-10-08	Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase
AU2021201399A1 (en)	2021-03-18	MDM2-based modulators of proteolysis and associated methods of use
NO20062370L (no)	2006-07-18	Amidderivater
NO20055421L (no)	2005-12-20	Kinolinderivater som fosfodiestrase-inhibitorer
DK1272477T3 (da)	2007-09-03	Pyrimidinforbindelser
NO20051826L (no)	2005-04-15	Heterosyklisk substituerte piperaziner for behandling av schizofreni
DK0958296T3 (da)	2003-08-18	Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
NO20062692L (no)	2006-08-14	Heterosykliske MEK inhibitorer og fremgangsmater for anvendelse derav
DK1378510T3 (da)	2006-10-16	Triazaspiro[5.5]undecan-derivater og lægemidler indeholdende disse som en aktiv bestanddel
NO20061700L (no)	2006-04-18	2-pyridonderivater som neutrofil elastase inhibitorer og deres anvendelse
EA200701268A1 (ru)	2007-12-28	Новые гетероциклические соединения, применяемые для лечения воспалительных и аллергических нарушений
NO20062726L (no)	2006-06-12	Nye pyridazin-3(2H)-on derivater
WO2002051819A3 (fr)	2002-12-05	Composés hétérocycliques antibactériens, mode d'élaboration et compositions pharmaceutiques ainsi obtenues
NO20084872L (no)	2009-02-03	2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
MX2007006821A (es)	2007-07-24	Derivados de 2,4 (4,6) pirimidina.
DE60024604D1 (de)	2006-01-12	Xanthinderivate und analoge als zellsignalisierung inhibitoren
NO20051527D0 (no)	2005-03-22	3-(sulfonamidoetyl) -indol-derivater for anvendelse som glukocorticoid-mimetica ved behandling av inflammatoriske, allergiske og proliferative sykdommer.
NO20070837L (no)	2007-04-16	Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
ATE359782T1 (de)	2007-05-15	Heteroaryl-substituierte pyrrol(2, 3- b)pyridin- derivate als crf-rezeptor-antagonisten
NO20082054L (no)	2008-06-02	Nye 2-fenylimidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase for behandling av demens og neurodegenerative forstyrrelser
ATE476431T1 (de)	2010-08-15	Piperidin- und azetidinderivate als glyt1- inhibitoren
NO20073436L (no)	2007-09-05	Nye heterosykliske forbindelser nyttige for behandling av inflammatoriske og allergiske forstyrrelser
NO20052182L (no)	2005-05-03	Nye forbindelser